Saving changes...

Done

Error

IVECCS 2016 MDR: Spinal Cord Injury

IVECCS 2016 MDR: Spinal Cord Injury

IVECCS 2016 MDR: Spinal Cord Injury

Daniel Fletcher, DVM
Daniel Fletcher, DVM
on behalf of Veterinary Emergency and Critical Care Society

$ 40.00 $ 40.00 $ 40.00

$ 40.00 $ 40.00 $ 40.00

$ 40.00 $ 40.00 $ 40.00
$ 40.00 $ 40.00 $ 40.00
Normal Price: $ 40.00 $ 40.00

Review:

Launch date: 31 Oct 2016

Expiry Date:

Last updated: 28 Oct 2017

Reference: 166863

$ 40.00 $ 40.00 $ 40.00
$ 40.00 $ 40.00 $ 40.00
IVECCS 2016 MDR: Spinal Cord Injury
Exam is embedded in the course
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

This lecture reviews the pathophysiology of the primary and secondary injury associated with acute spinal cord injury (ASCI) and the evidence for and against the use of medical therapies to ameliorate secondary injury. Classic and recent clinical trials examining the efficacy of glucocorticoids, polyethylene glycol, and therapeutic hypothermia as treatment for secondary injury are discussed and indications for surgical treatment and recommendations for timing of surgical management are reviewed.

Objectives

Describe the types of primary injury associated with acute spinal cord injury
Primary injury occurs at the time of the spinal trauma and includes bleeding, fracture, luxation, and direct axonal injury.
Explain the biochemical processes of secondary spinal injury that lead to continued neurologic injury after acute spinal cord injury
Secondary injury occurs in the days to weeks after a primary spinal cord injury and includes neuroinflammation, ischemia-reperfusion injury, and excitotoxicity.
Describe the evidence for and against the use of methylprednisolone sodium succinate (MPSS) in patients with acute spinal cord injury
The use of MPSS in human acute spinal cord injury was motivated by the NASCIS-2 trial, but more recent studies have shown increased side effects and minimal benefit of this drug in people and dogs.
Daniel Fletcher, DVM

Author Information Play Video Bio

Daniel Fletcher, DVM
on behalf of Veterinary Emergency and Critical Care Society

Dan Fletcher obtained his BS in Electrical Engineering at Drexel University and PhD in Bioengineering at UC Berkeley/UC San Francisco before completing his DVM at UC Davis, followed by an internship and residency in Emergency and Critical Care at the University of Pennsylvania. His current interests include immersive simulation and virtual patients for veterinary student training, cardiopulmonary resuscitation, and disorders of fibrinolysis. He recently received the 2012 SCAVMA Teaching Award for Clinical Sciences, the 2013 State University of New York Chancellor's Award for Excellence in Teaching, and the 2013 Cornell University College of Veterinary Medicine Department of Clinical Sciences Innovative Teaching Award.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • AAVSB-Registry of Approved Continuing Education (RACE)
  • 1.00 Hours -
    Exam Attempts: 3
    -
    Exam Pass Rate: 70

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error